2025-2034 Sexually Transmitted Infections (STIs) Market Outlook: Key Drivers, Emerging Challenges, and Strategic Insights

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Sexually Transmitted Infections (STIs) Industry Market Size Be by 2025?
Recent years have witnessed substantial expansion in the market for sexually transmitted infections (STIs), projected to increase from a valuation of $63.69 billion in 2024 to $71.28 billion by 2025, reflecting an 11.9% compound annual growth rate; this upward trajectory during the preceding period was fueled by shifts in behavior, enhanced educational initiatives and public awareness campaigns, improved availability of medical care, and advancements in antibiotic research and production.

What's the Long-Term Growth Forecast for the Sexually Transmitted Infections (STIs) Market Size Through 2029?
Anticipation is for substantial expansion within the sexually transmitted infections (STIs) market over the ensuing years, projecting it to reach a valuation of $112.02 billion by 2029, propelled by a compound annual growth rate (CAGR) registering at 12.0%. This upward trajectory throughout the projection timescale is underpinned by factors such as the advent of novel STI strains, expanded vaccination programs, increasing adoption of telemedicine and at-home testing options, alongside a greater focus on sexual health equity; concurrently, key developments shaping this period will involve the increasing prevalence of antimicrobial resistance, wider availability of pre-exposure prophylaxis (PrEP), trends toward at-home STI self-management, and strengthened sexual education efforts.

View the full report here:
https://www.thebusinessresearchcompany.com/report/sexually-transmitted-infections-stis-global-market-report

What Are the Key Growth Drivers Fueling the Sexually Transmitted Infections (STIs) Market Expansion?
Anticipation is high for an upswing in the sexually transmitted infections (STIs) market, largely fueled by increasing governmental efforts aimed at broadening public knowledge regarding these infections. Governmental actions, defined as specific programs or policies enacted to tackle defined issues and reach set objectives, manifest in various forms intended for the prevention, containment, and management of STIs. These governmental supports can include financial backing for public awareness campaigns educating on STIs, the provision of vaccines against specific STIs, and the offering of testing and screening services either without charge or at subsidized rates. An illustration of this commitment involves the April 2023 announcement by Springfield-Greene County Health, a public health entity in the US, regarding the launch of Disease Intervention Specialist (DIS), a collaborative new venture with the Missouri Department of Health and Senior Services (Missouri DHSS) designed to curb the escalating transmission of STIs within Greene County. Specialists within the DIS structure, concentrating mainly on Syphilis and HIV, are tasked with reaching out to individuals who receive a positive diagnosis, linking them to available therapies, and tracing contacts to inform them about potential exposure. Consequently, the boost in governmental programs is projected to be a key catalyst for expansion within the STIs market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13047&type=smp

What Are the Key Trends Driving Sexually Transmitted Infections (STIs) Market Growth?
Key players in the sexually transmitted infections (STIs) market are striving for a leading edge by bringing out novel diagnostic tools that leverage fluorescent Polymerase Chain Reaction (PCR) methodology. This molecular biology advancement, fluorescent PCR, serves to identify and measure the precise quantity of target DNA sequences present within a specimen. Illustratively, in March of 2023, the Chinese molecular diagnostics specialist, Jiangsu Bioperfectus Technologies Co. Ltd., launched a pair of novel real-time PCR assay kits: the Mycoplasma Hominis Real-Time PCR Kit and the Treponema Pallidum Real-Time PCR Kit. These newly released assay packages offer a comprehensive PCR platform facilitating the prompt identification of sexually transmitted diseases that affect substantial populations. Employing fluorescent PCR techniques, the BioPerfectus Mycoplasma Hominis Real-Time PCR Kit functions as a reagent capable of locating Mycoplasma hominis DNA in samples derived from male urethral swabs, female cervical or vaginal swabs, and urine specimens. Furthermore, the BioPerfectus Treponema Pallidum Real-Time PCR Kit has been engineered for the specific purpose of identifying Treponema pallidum genetic material within human serum and plasma samples.

How Is the Sexually Transmitted Infections (STIs) Market Segmented?
The sexually transmitted infections (stis)market covered in this report is segmented -

1) By Type: Human Immunodeficiency Virus (HIV); Human Papilloma Virus (HPV); Gonorrhea; Syphilis; Other Types
2) By Treatment: Antibiotics; Antiviral
3) By Location Of Testing: Laboratory Testing; Point-Of-Care (POC) Testing
4) By Route Of Administration: Oral; Parenteral; Other Route Of Administration
5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users

Subsegments:
1) By Human Immunodeficiency Virus (HIV): HIV Type 1; HIV Type 2
2) By Human Papilloma Virus (HPV): Low-Risk HPV; High-Risk HPV
3) By Gonorrhea: Uncomplicated Gonorrhea; Complicated Gonorrhea
4) By Syphilis: Primary Syphilis; Secondary Syphilis; Tertiary Syphilis
5) By Other Types: Chlamydia; Herpes Simplex Virus (HSV); Hepatitis B; Hepatitis C; Trichomoniasis

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13047&type=smp

Which Companies Are Leading the Charge in Sexually Transmitted Infections (STIs) Market Innovation?
Major companies operating in the sexually transmitted infections (stis) market are Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy's Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd.

Which Regions Are Leading the Global Sexually Transmitted Infections (STIs) Market in Revenue?
North America was the largest region in the sexually transmitted infection (STIs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sexually transmitted infections (STIs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13047

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.